We view partnership as essential for our success. We interact with open communication and a team approach. We commit ourselves to the projects we share with partners to make their products a success.
| Partner
|
Indication
|
Development Stage
|
Agreement & Year
|
|---|---|---|---|
| AbGenomics
|
Immunology
|
Development
|
Development & License Agreement, 2005
|
| Ablynx
|
Alzheimer's disease Multiple therapeutic areas
|
Discovery
|
Research Collaboration & License Agreement, 2007
|
| Actimis
|
Asthma, Allergic rhinitis
|
Development
|
Share Purchase and License Agreement, 2008
|
| Biolipox
|
CNS (chronic pain)
|
Pre-clinical
|
Research Collaboration & License Agreement, 2005
|
| DeveloGen
|
Metabolic diseases
|
Pre-clinical
|
Asset Purchase and Collaboration Agreement, 2009
|
| DxS | Lung Cancer
|
Companion Diagnostic | Diagnostic Collaboration Agreement 2009
|
| Evec
|
Therapeutic antibody programme
|
Pre-clinical
|
License Agreement, 2008
|
| Evotec
|
GPCR
|
Discovery
|
Research Alliance, 2004
|
| Exelixis
|
Autoimmune diseases
|
Pre-clinical
|
Collaboration Agreement, 2009
|
| Neurocrine | Metabolic Diseases | Pre-clinical | Research Collaboration and License Agreement 2010
|
| Priaxon
|
Oncology
|
Pre-clinical
|
Collaboration & License Agreement 2009
|
| Vitae
|
Metabolic diseases
|
Pre-clinical
|
License Agreement, 2007
|
| Vitae
|
Alzheime’s Disease
|
Pre-clinical
|
Research Collaboration 2009 |
Status: Aug. 2010